Talking about what others are afraid to say
The pharma industry has poured billions into educating physicians and patients that GLP-1’s can alter your life. Plenty of data backs this up. What pharma should be asking is. What …
Writing an Rx for a GLP-1 Drug isn’t Good Enough Read More
There is something surreal about watching television and seeing an advertisement for a cancer drug. A patient is walking on a beach. A family is laughing around a dinner table. …
The Absurdity of Advertising Oncology Drugs Read More
Let’s begin with something Revolution Medicines absolutely deserves credit for. RASONQUE is not another me-too cancer drug with a numerically small but statistically significant improvement that you have to massage …
Revolution Medicines Did Something Extraordinary. Then It Put a $477,600 Price Tag on It. Read More
You can hardly think of a better example of everything that is wrong with the U.S. drug patent system than AbbVie’s monster blockbuster Humira. Undoubtedly, Humira was a transformative medicine. …
How Much Has AbbVie Cost U.S. Healthcare by Gaming the Patent System? Read More
Big Pharma has long defended its high drug prices by citing the patent system’s core purpose, arguing that patents are inherently designed to reward innovation. This logic has merit: new …
How Big Pharma Exploits the Patent System to Keep Drug Prices High Read More
Bristol Myers Squibb announced this week that it is working with Anthropic to deploy the AI tool Claude throughout its operations. Predictably, the headlines framed this as another bold step …
Bristol Myers Squibb’s AI Obsession Is Corporate Theater Read More
Rhetoric and reality are not the same thing. In early 2026, Big Pharma raised prices on 64 cancer drugs. Not modest adjustments. Not inflation-level increases. Most of these hikes exceeded …
Big Pharma Says One Thing. Cancer Patients Live Another Reality. Read More
There seems to be widespread confusion in biotechs about off-label communication—despite the rules being clear. Sales representatives may only discuss information that appears on the FDA-approved label. Off-label promotion by …
Off-Label Confusion: This Should Not Be Complicated (But Somehow Still Is) Read More